Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 20/20 | 0.71 |
| ▸ | ITGAV | P06756 | 20/20 | 0.71 |
| ▸ | ITGA2B | P08514 | 3/20 | 0.71 |
| ▸ | ITGB5 | P18084 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7915919 | 0.83 | ITGB3 (1.00) | ITGB3ITGAVITGA2B | |
| SCHEMBL7553511 | 0.83 | ITGB3 (1.00) | ITGB3ITGAVITGA2B | |
| Trifluoroacetic Acid SCHEMBL6422001 | 0.81 | ITGAV (0.91) | ITGB3ITGAVITGB5 | |
| SCHEMBL20157728 | 0.78 | ITGB3 (0.75) | ITGB3ITGAVITGA2BITGB5 | |
| SCHEMBL21314487 | 0.78 | ITGB3 (0.75) | ITGB3ITGAVITGA2BITGB5 | |
| SCHEMBL20157727 | 0.78 | ITGB3 (0.75) | ITGB3ITGAVITGA2BITGB5 | |
| SCHEMBL29701354 | 0.78 | ITGB3 (0.75) | ITGB3ITGAVITGA2BITGB5 | |
| SCHEMBL21314389 | 0.78 | ITGB3 (0.75) | ITGB3ITGAVITGA2BITGB5 | |
| SCHEMBL6422671 | 0.77 | ITGB3 (1.00) | ITGB3ITGAVITGB5 | |
| SCHEMBL6420861 | 0.77 | ITGB3 (1.00) | ITGB3ITGAVITGB5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0934305-A4 | INTEGRIN ANTAGONISTS | MERCK & CO INC (US) | 2001-04-11 | — | — | EP | claimed |
| US-5981546-A | Integrin antagonists | MERCK & CO., INC. (US) | 1999-11-09 | — | — | US | claimed |
| EP-0934305-A1 | INTEGRIN ANTAGONISTS | Merck & Co., Inc. (US) | 1999-08-11 | — | — | EP | claimed |
| WO-1998008840-A1 | INTEGRIN ANTAGONISTS | MERCK & CO., INC. (US) | 1998-03-05 | — | — | WO | claimed |
| EP-0934305-A4 | INTEGRIN ANTAGONISTS | MERCK & CO INC (US) | 2001-04-11 | — | — | EP | disclosed |
| US-6211184-B1 | TETRAHYDRO-PYRAZINE OR PYRIMIDINE DERIVATIVES; VITRONECTIN RECEPTOR ANTAGONIST; OSTEOPOROSIS; ANTIINFLAMMATORY, ANTITUMOR AGENTS; ANGIOGENESIS AND RESTENOSIS INHIBITORS | MERCK & CO., INC. | 2001-04-03 | — | — | US | disclosed |
| US-5981546-A | Integrin antagonists | MERCK & CO., INC. (US) | 1999-11-09 | — | — | US | disclosed |
| EP-0934305-A1 | INTEGRIN ANTAGONISTS | Merck & Co., Inc. (US) | 1999-08-11 | — | — | EP | disclosed |
| WO-1998008840-A1 | INTEGRIN ANTAGONISTS | MERCK & CO., INC. (US) | 1998-03-05 | — | — | WO | disclosed |